American Diabetes Association
2 files

Human T2D associated gene IMP2/IGF2BP2 promotes the commitment of mesenchymal stem cells into adipogenic lineage

Version 2 2022-10-28, 17:09
Version 1 2022-10-11, 20:00
posted on 2022-10-28, 17:09 authored by Laura Regue, William Wang, Fei Ji, Joseph Avruch, Hua Wang, Ning Dai

Excessive adiposity is the main cause of obesity and type two diabetes (T2D). Variants in human IMP2/IGF2BP2 gene are associated with increased risk of T2D. However, little is known about its role in adipogenesis and in insulin resistance. Here, we investigate the function of IMP2 during adipocyte development. Mice with IMP2 deletion in mesenchymal stem cells (MSCs) are resistant to diet-induced obesity without affecting glucose and insulin tolerance. IMP2 is essential for the early commitment of adipocyte derived stem cells (ADSCs) into preadipocytes; but the deletion of IMP2 in MSCs is not required for the proliferation and terminal differentiation of committed preadipocytes. Mechanistically, IMP2 binds Wnt receptor FDZ8 mRNA and promotes its degradation by recruiting CCR4–NOT deadenylase complex in a mTOR dependent manner. Our data demonstrate that IMP2 is required for maintaining white adipose tissue (WAT) homeostasis by controlling mRNA stability in ADSCs. However, the contribution of IMP2 to insulin resistance, a main risk of T2D, is not evident.


This work was supported by NIH grants DK17776, DK057521, and MGH institutional funds